IMed Consultancy, a leading Oxfordshire-based provider of regulatory and compliance services for the global medical technology industry, has launched a new whitepaper to help innovators navigate the complex regulatory landscape for digital mental health tools.
The free publication, titled ‘Mental Health Goes Digital: A Blueprint for Digital Health Medical Technologies (DHMTs)‘, explores the latest guidance from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA).
It offers practical advice to developers seeking to understand whether their digital solutions — particularly those integrating Artificial Intelligence (AI) or Large Language Models (LLMs) — should be classified and regulated as medical devices.
With cases of depression, anxiety and related disorders on the rise worldwide, demand for accessible digital mental health support is growing rapidly. However, the surge in innovation has created confusion over compliance standards and blurred the lines between lifestyle apps and clinical medical devices.
“Digital mental health technologies are reshaping the way care is delivered, but innovators must navigate an increasingly complex regulatory environment,” said Jonathan Ripley, Managing Director at IMed Consultancy. “Our new whitepaper helps companies understand the latest MHRA guidance and prepare for safe, compliant market entry.”
As AI becomes more deeply embedded in healthcare, the MHRA’s clearer framework on defining and managing medical-grade digital tools represents a welcome step toward greater safety and transparency.
Benjamin Austin, Senior QA/RA Consultant for SaMD/AI at IMed Consultancy, added: “Understanding whether your digital mental health product qualifies as a medical device is of critical importance. Our goal is to equip innovators with the knowledge and tools to confidently bring effective, compliant technologies to market.”
The whitepaper outlines classification criteria, regulatory pathways, and the evolving expectations for AI-powered systems in healthcare, offering developers a practical roadmap to compliance.
The document can be downloaded free on IMed Consultancy website.
Founded in 2012, IMed Consultancy provides expert regulatory and quality assurance services for medical and health technology manufacturers worldwide. Its team of experienced professionals supports clients across the full product lifecycle — from concept and clinical studies through post-market surveillance — ensuring compliance in the UK, EU, and global markets.
